Back

Incidence and predictors of silent cerebral thromboembolic lesions after catheter ablation for atrial fibrillation in patients treated with non-vitamin K antagonist oral anticoagulants

28 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 2 - Stroke: anticoagulation, PFO closure, LAA closure Stroke ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Atsushi Doi

National Cerebral and Cardiovascular Center Hospital, Osaka (Japan)

17 More presentations in this session

Presentation thumbnail
Professor S. Aguiar (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Associate Professor M. Komar (Krakow, PL)
Abstract
Presentation thumbnail
Doctor P. Mazzone (Milan, IT)
Abstract Slides
Presentation thumbnail
Associate Professor B. Kim (Busan, KR)
Abstract Slides
Presentation thumbnail
Associate Professor K. Ibrahim (Chemnitz, DE)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Stroke: anticoagulation, PFO closure, LAA closure

The Event

Event poster

ESC Congress 2016

28 August 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Cerebral microembolization detected by transcranial doppler and cerebral MRI in atrial fibrillation ablation using a VLCC
14 April 2026
thumbnail
Congress Presentation
The prevalence and safety of direct oral anticoagulants in patients with non-atrial fibrillation associated intra-cardiac thrombus
27 August 2021
thumbnail
Congress Presentation
NOACs preserve cognitive performance in hypertensive patients with atrial fibrillation
29 June 2021
thumbnail
Congress Presentation
Atrial abnormalities predict silent atrial fibrillation in patients with crytogenic stroke with an internal loop recorder
1 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources